Sumatriptan
Sumatriptan (Imitrex®) is a triptan drug originally developed by Glaxo for the treatment of migraine headaches. Several dosage forms for sumatriptan have been approved, including tablets, solution for injection, and nasal inhalers.
| sumatriptan | |
| 4-methylaminosulfonyl-N,N-dimethyltryptamine | |
| Chemical formula | CHNOS . CH6O4 |
| Molecular weight | 413.5 |
| Bioavailability | 15% |
| Metabolism | ? |
| Elimination half life | 2.5 hours |
| Excretion |
60% urine 40% feces |
| Pregnancy category | C |
| Delivery | 25mg and 50mg tablets |
|
Indicated for: | |
Contraindications:
| |
|
Side effects:
Severe:
Atypical sensations: Cardiovascular: Ear, nose, and throat:
| |
This article is a stub. You can help Wikipedia by [ expanding it].
| Triptans |
|---|
| {Almotriptan} {Eletriptan} {Frovatriptan} {Naratriptan} {Sumatriptan} {Rizatriptan} {Zolmitriptan} |
This article is part of the Wikiproject on Drugs, which is an attempt to to facilitate the categorization and creation of professional-looking drug-related articles on Wikipedia. If you are interested in editing this article, please see its and make sure your edits are consistent with the goals of our project.